SEC Form 4 · accession 0001209191-19-005412
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Sheridan
Officer — EVP, CHIEF OPERATING OFFICER
Period of report
Jan 25, 2019
Accepted (ET)
Jan 25, 2019 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 25, 2019 | M | 20,000 | $2.59 | A | 20,666 | D | |
| Common StockF2 | Jan 25, 2019 | S | 20,000 | $45.2589 | D | 666 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $2.59 | Jan 25, 2019 | M | 20,000 | D | — | Dec 1, 2027 | Common Stock | 20,000 | 60,000 | D |
Explanation of responses
- F1Represents shares of common stock received upon exercise of a stock option award.
- F2The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29,2018, in multiple transactions at prices ranging from $45.00 to $45.81.
- F3Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter